Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Background An enhanced inflammatory response predicts worse outcomes in heart failure
(HF). We hypothesized that administration of IL-1 (interleukin-1) receptor antagonist …
(HF). We hypothesized that administration of IL-1 (interleukin-1) receptor antagonist …
Usefulness of C-reactive protein plasma levels to predict exercise intolerance in patients with chronic systolic heart failure
JMN Canada, DT Fronk, LF Cei, S Carbone… - The American Journal of …, 2016 - Elsevier
Patients with heart failure (HF) have evidence of chronic systemic inflammation. Whether
inflammation contributes to the exercise intolerance in patients with HF is, however, not well …
inflammation contributes to the exercise intolerance in patients with HF is, however, not well …
Severely impaired cardiorespiratory fitness in patients with recently decompensated systolic heart failure
Hospital admission for decompensated heart failure marks a critical inflection point in a
patient's health. Despite the improvement in signs or symptoms during hospitalization …
patient's health. Despite the improvement in signs or symptoms during hospitalization …
[引用][C] Interleukin-1 blockade in recently decompensated systolic heart failure
R Arena, R Melchior, M Del Buono - Circ Hear Fail, 2017